Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 17/20 | 0.82 |
| ▸ | MMP14 | P50281 | 4/20 | 0.82 |
| ▸ | MMP13 | P45452 | 6/20 | 0.64 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.62 |
| ▸ | MMP7 | P09237 | 1/20 | 0.62 |
| ▸ | MMP12 | P39900 | 1/20 | 0.62 |
| ▸ | BCAT1 | P54687 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3612416 | 0.91 | MMP2 (1.00) | MMP2MMP14MMP13ADAMTS4MMP7 | |
| SCHEMBL2380526 | 0.91 | MMP2 (1.00) | MMP2MMP14MMP13ADAMTS4MMP7 | |
| SCHEMBL3622220 | 0.85 | MMP2 (0.87) | MMP2MMP14MMP13ADAMTS4MMP7 | |
| SCHEMBL3612423 | 0.79 | MMP2 (0.83) | MMP2MMP14MMP13ADAMTS4MMP7 | |
| SCHEMBL5787705 | 0.79 | MMP2 (0.83) | MMP2MMP14MMP13ADAMTS4MMP7 | |
| SCHEMBL3612421 | 0.79 | MMP2 (0.83) | MMP2MMP14MMP13ADAMTS4MMP7 | |
| SCHEMBL3618625 | 0.79 | MMP2 (0.83) | MMP2MMP14MMP13ADAMTS4MMP7 | |
| SCHEMBL3618623 | 0.79 | MMP2 (0.83) | MMP2MMP14MMP13ADAMTS4MMP7 | |
| SCHEMBL3607665 | 0.79 | MMP2 (0.81) | MMP2MMP14MMP13ADAMTS4MMP7 | |
| SCHEMBL12247610 | 0.79 | MMP2 (0.81) | MMP2MMP14MMP13ADAMTS4MMP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2681209-B1 | COMPOUNDS AND METHODS FOR THE TREATMENT OF PAIN AND OTHER DISORDERS | AQUILUS PHARMACEUTICALS INC (US) | 2018-05-09 | — | — | EP | disclosed |